Ivermectin pills (a broad-spectrum antiparasitic agent) on top of instruction label

Antiparasitic Drug Could Help Treat Mild COVID-19 Cases

While this study requires validation in a bigger patient group, the initial results suggest that one dose of ivermectin given to mild COVID-19 patients reduced viral load and the duration of symptoms such as cough and loss of smell and taste.
Alzheimer's disease: the amyloid-beta peptide accumulates to amyloid fibrils that build up dense amyloid plaques.

Abnormal MicroRNAs Could Link Brain Injury with Alzheimer’s

Research suggests that a build-up of abnormal microRNAs could be behind the increased risk for Alzheimer’s disease seen in patients who have experienced traumatic brain injury.
Triple negative breast cancer cell undergoing retraction and apoptosis

Researchers Activate Antiviral Immune Pathways in Triple Negative Breast Cancers

The study shows that endogenous mis-spliced RNA in tumor cells mimics an RNA virus, leading tumor cells to self-destruct as if fighting an infection.
Illustration of a blood clot showing a clump of red blood cells intertwined in a fibrin mesh

Autoantibodies in COVID-19 Promote Blood Clots

About half of the patients who were very sick with COVID-19 were exhibiting a combination of high levels of both the dangerous antibodies and super-activated neutrophils, which are destructive, exploding white blood cells.

Lab-on-a-Chip Infection Test Could Lead to Novel Portable Diagnostics

Dubbed TriSilix, the chip performs a miniature version of polymerase chain reaction (PCR) testing on bodily fluids, feces, or environmental samples, according to the scientists at Imperial College London who developed the new technology.
Researching vaccine to novel coronavirus 2019-nCoV. Close-up shot of a scientist preparing glass slide.

Regeneron, Moderna Return Encouraging Early Data on COVID-19 Clinical Trials

Moderna said its vaccine candidate produced neutralizing antibodies in older and elderly adults, while Regeneron said REGN-COV2 rapidly reduced viral load as well as time to alleviate symptoms in non-hospitalized patients.
Antibodies responding to coronavirus particles, illustration

SARS-CoV-2 Antibodies Decrease Three Months After Infection

The study is one of the first longitudinal analyses to show that people who were seropositive—that is, they had produced antibodies against the virus that causes COVID-19—become seronegative, which means there were no detectable antibodies after a certain point.

Rapid PCR-Based Test Developed to Detect Pneumonia in Patients with Severe COVID-19

Normally, confirming a pneumonia diagnosis requires growing bacterial samples from patients in a lab, which is time-consuming. The new test can identify 52 different pathogens, and can be done in around four hours, without needing to grow the bacteria.
Man Breathing Through Cutout View of Nasal Passages

SARS-CoV-2 May Gain Brain Entry via the Nose

Autopsies have shown the presence of SARS-CoV-2 RNA and protein in anatomically distinct regions of the nasopharynx and brain, suggesting it enters the brain through the nose, and may inform diagnosis and measures to prevent infection.
DNA Binary

Language Algorithms Shed Light on How Viruses Like SARS-CoV-2 Mutate to Avoid Immune System

The researchers trained a natural language processing model to analyze patterns found in genetic sequences, which allowed it to predict new sequences that have new functions but still follow the biological rules of protein structure.
Fetus with DNA ambilocal chord

NIPT Builds on Its Success

With guidelines for noninvasive prenatal testing expanding and payers reimbursing for these screenings, researchers search for new testing methods. Noninvasive prenatal testing brought genetics to the very core of clinical practice.

Genetic Counseling for All

In the 1990s, Elissa Levin proposed a master’s thesis on using the Internet to extend the reach of genetic counselors. Quickly, her committee shut...
Scientists Loading Centrifuge

Testing Conundrum

When Congress reconvenes in January, the lengthy docket of action items is expected to include proposed solutions to the years-long conundrum over how to...
Glowing Blue Honeycomb

Seeing Real-Time Biological Interactions with Graphene Transistors

Michael Heltzen, CEO and co-founder of Cardea Bio, a San Diego startup integrating tiny bits of biology into modern electronics, believes that the way...
Scroll Up